Guidance: Medicines eligible for Northern Ireland MHRA Authorised Route
Sets out medicines that can be moved to Northern Ireland to meet patient need.
The latest headlines across every section, pulled from official and open-access sources.
Sets out medicines that can be moved to Northern Ireland to meet patient need.
by Gabriela Lima de Melo Ghisi, Rachael P. Carson, Karam Turk Adawi, Rongjing Ding, Warner M. Mampuya, Mariya P. Jiandani, Jimena Martinez, Monserrat Cruz Rivero, Claudia V. Anchique, Dinah L. van Schalkwijk, Jonathan Gallagher, Buket Akinci, Dion Candelaria, Jirapa Champaiboon, Daniel F. Quesada-Chaves, Tone M. Norekvål, Iwona Szadkowska, Borut Jug, Evangelia Kouidi, Marta Supervia, Won-Seok Kim, Chamila Mettananda, Lilian Mbau, Gulsim T. Aimakova, Sherry L. Grace, on behalf of the ICCPR Global Cardiac Rehabilitation Audit Update Investigators Background Cardiovascular disease (CVD) remains a…
by Tom A. Bond, Tom A. McAdams, Nicole M. Warrington, Laurie J. Hannigan, Espen Moen Eilertsen, Ziada Ayorech, Fartein A. Torvik, George Davey Smith, Deborah A. Lawlor, Eivind Ystrom, Alexandra Havdahl, David M. Evans Background The intergenerational transmission of obesity-related traits could propagate an accelerating cycle of obesity, if parental adiposity causally influences offspring adiposity. The extent to which intergenerational obesity associations are due to such causal effects, as opposed to genetic confounding (inheritance), is unclear. We aimed to establish whether associations…
by Aisha Osman, Hina Akram, Bayan Alemrayat, Sumaya Al-Maraghi, Manale Harfouche, Laith J. Abu-Raddad Background Neisseria gonorrhoeae (NG) infection is a global health concern because of its morbidity and increasing antimicrobial resistance. Sub-Saharan Africa is believed to carry a disproportionately high burden of NG infection, but the epidemiology of NG infection in this region has not been comprehensively synthesized. This study systematically reviewed and analyzed NG prevalence in sub-Saharan Africa to characterize prevalence patterns and identify populations at risk. Methods and…
by Giulia Iacono, Christina Begka, Bailey Cardwell, Carmel Daunt, Roxanne Chatzis, Celine Pattaroni, Alana Butler, Matthew Macowan, Bronwyn Levvey, Gregory I. Snell, Glen P. Westall, Benjamin J. Marsland Background Long-term survival of lung transplant recipients remains limited by chronic lung allograft dysfunction (CLAD). CLAD is only diagnosed following a persistent and substantial decline in lung function, after which irreversible damage to the lungs has occurred, limiting opportunities to effectively intervene at an early stage. There is a critical need for earlier detection prior to its…
Organizations that are experiencing significant improvements related to AI are not necessarily using more advanced tools. They are just using the tools they have with more intention. The post Why Healthcare AI is Missing the Point appeared first on MedCity News .
Providers don’t need to endorse ibogaine treatment to take this moment seriously. They need to understand it, respect the risk, and prepare for those already seeking it. The post Ibogaine and SUD Treatment: Signal, Risk, and the Role of Providers appeared first on MedCity News .
This is not an abstract discussion. It is about sustaining the organizations, employees, and communities that depend on us. If we fail to account for how these policies interact in the real world, we risk weakening the very system we are trying to improve. The post Washington’s Medical Debt Push Risks Missing the Bigger Healthcare Crisis appeared first on MedCity News .
In this interview, Kim Allan Williams Sr., MD, MACC and Misa Fister, MD, PhD examine ‘Prehospital Heparin Administration In Patients With STEMI Undergoing Primary PCI’.
Appeals and grievances reflect how well a health plan functions under pressure. They also show how effectively your organization can surface, prioritize, and resolve the cases that matter most. The post Why So Few Appeals Happen and What That Reveals About Health Plans appeared first on MedCity News .
Source: Centers for Disease Control and Prevention Related MedlinePlus Pages: Streptococcal Infections
Explore the FDA’s Competitive Generic Therapy Approvals page, offering insights into the program designed to encourage generic drug competition. Access information about approved CGT products and find resources, including a downloadable CGT approvals spreadsheet.
Source: Centers for Disease Control and Prevention Related MedlinePlus Pages: Streptococcal Infections
Marketing authorisations granted in 2026.
Parallel import licences granted in 2026.
Information on the Global Polio Eradication programme, UK National Authority for Containment (NAC) and environmental surveillance for polio.
The World Health Organization (WHO) today calls on countries to expand newborn screening for birth defects, highlighting how early detection and treatment can save lives and reduce lifelong disability for millions of children. A new WHO report, Strengthening capacity for newborn screening, diagnosis and management of birth defects , identifies newborn screening as an important opportunity to accelerate progress in child survival. Many conditions can be successfully treated if identified early after birth. These include congenital hypothyroidism, sickle-cell disease, hearing impairment and some…
Being a caregiver can start long before you go to a doctor appointment with a loved one or move your parents into your house. The HealthQ team explores how embracing the role matters — and how the recognition and support that come next can ease a difficult season of life.
Medicare is testing the use of artificial intelligence to preapprove several healthcare services. Federal health officials say prior authorization can help reduce fraud and contain costs. But doctors and patients describe the trial as “horrendous” and full of red tape so far.
Insights on the vaccine uptake and commentary on the RSV (respiratory syncytial virus) vaccination programme for pregnant women.
Apogee Therapeutics brings AbbVie a long-acting antibody ready for Phase 3 testing in atopic dermatitis, also called eczema. This therapy’s pipeline in a product potential includes respiratory conditions such as asthma — as a monotherapy and as part of novel drug combinations. The post AbbVie’s $11B Apogee Acquisition Brings an Eczema Drug With an Edge appeared first on MedCity News .
B. Rubbab et al.
P. Roychoudhury et al.
J. L. Scott et al.